South Dakota medicine : the journal of the South Dakota State Medical Association · 2025
Understanding Kratom: Pharmacology, Risks, and Relevance to South Dakota Providers.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Thelen Kianna, Cooper Carly, Schimelpfenig Michelle
Аннотация
INTRODUCTION: Kratom (Mitragyna speciosa), a Southeast Asian botanical, has gained increasing popularity in the U.S. for its stimulant and opioid-like effects. As its use grows, providers face challenges in understanding its pharmacology, clinical risks, and regional impact.
METHODS: This narrative review synthesizes existing literature on kratom's pharmacological profile, clinical implications, regulatory status, and poison control trends, with a particular emphasis on South Dakota.
RESULTS: Kratom contains mitragynine and 7-hydroxymitragynine, alkaloids with activity at opioid receptors. Its effects vary by dose, ranging from stimulation to sedation. Though often used for pain and opioid withdrawal, kratom carries risks such as dependency, hepatotoxicity, seizures, and death-particularly when combined with other substances. South Dakota-specific poison control data reveal a significant uptick in kratom-related calls, aligning with national increases.
CONCLUSION: Kratom remains legal and accessible in South Dakota, contributing to rising clinical encounters. Providers should screen for use, understand its dose-response profile, and be prepared to address associated complications.
METHODS: This narrative review synthesizes existing literature on kratom's pharmacological profile, clinical implications, regulatory status, and poison control trends, with a particular emphasis on South Dakota.
RESULTS: Kratom contains mitragynine and 7-hydroxymitragynine, alkaloids with activity at opioid receptors. Its effects vary by dose, ranging from stimulation to sedation. Though often used for pain and opioid withdrawal, kratom carries risks such as dependency, hepatotoxicity, seizures, and death-particularly when combined with other substances. South Dakota-specific poison control data reveal a significant uptick in kratom-related calls, aligning with national increases.
CONCLUSION: Kratom remains legal and accessible in South Dakota, contributing to rising clinical encounters. Providers should screen for use, understand its dose-response profile, and be prepared to address associated complications.